{"id":2017,"date":"2026-08-28T19:44:06","date_gmt":"2026-08-28T19:44:06","guid":{"rendered":"https:\/\/staging.bycellmind.com\/retatrutide-triple-glp-peptid\/"},"modified":"2026-08-28T19:44:06","modified_gmt":"2026-08-28T19:44:06","slug":"retatrutide-triple-glp-peptid","status":"publish","type":"post","link":"https:\/\/staging.bycellmind.com\/hr\/retatrutide-triple-glp-peptid\/","title":{"rendered":"Retatrutide: triple GLP peptid koji redefinira metaboli\u010dka istra\u017eivanja"},"content":{"rendered":"<p>Dok biohacking zajednica u Hrvatskoj tek po\u010dinje ozbiljnije razgovarati o GLP peptidima, istra\u017eiva\u010dka zajednica globalno ve\u0107 intenzivno prou\u010dava sljede\u0107i korak \u2014 triple receptor aktivaciju. Retatrutide, poznat i kao LY3437943, predstavlja upravo to: jedan peptid koji simultano cilja GLP-1, GIP i Glucagon receptor.<\/p>\n<p>Za istra\u017eiva\u010da koji ve\u0107 poznaje Tirzepatide kao dual agonist, Retatrutide je logi\u010dan sljede\u0107i korak u razumijevanju kompleksnosti metaboli\u010dkih putova i jedina molekula u ovoj klasi koja istovremeno aktivira sve tri osi.<\/p>\n<h2>Tri receptora \u2014 \u0161to to zna\u010di u praksi?<\/h2>\n<p>GLP-1 receptor \u2014 modulira lu\u010denje inzulina ovisno o glukozi, usporava pra\u017enjenje \u017eeluca, utje\u010de na osje\u0107aj sitosti. Najprou\u010davaniji od tri.<\/p>\n<p>GIP receptor \u2014 u kombinaciji s GLP-1 pokazuje poja\u010dani inzulinotropni odgovor. Tirzepatide ve\u0107 aktivira ova dva \u2014 Retatrutide ide dalje.<\/p>\n<p>Glucagon receptor \u2014 aktivacija pove\u0107ava hepati\u010dku glukoneogenezu i lipolizu. Ovo je komponenta koja Retatrutide \u010dini strukturno druga\u010dijim od svih dual agonista i otvara nova istra\u017eiva\u010dka pitanja o hepati\u010dkim metaboli\u010dkim procesima.<\/p>\n<h2>\u0160to pokazuju pretklini\u010dka istra\u017eivanja?<\/h2>\n<p>Studije na pretklini\u010dkim modelima koje su koristile Retatrutide bilje\u017ee:<\/p>\n<ul>\n<li>Zna\u010dajno ve\u0107u redukciju tjelesne mase u usporedbi s dual agonistima u mi\u0161jim modelima pretilosti \u2014 razlika koja se pripisuje Glucagon komponenti koja poja\u010dava lipolizu<\/li>\n<li>Promjene u hepati\u010dkim metaboli\u010dkim markerima koje se ne bilje\u017ee kod Tirzepatide grupe, \u0161to upu\u0107uje na specifi\u010dan doprinos Glucagon komponente<\/li>\n<li>Pobolj\u0161ane markere lipidnog metabolizma u \u017eivotinjskim modelima<\/li>\n<li>Promjene u markerima glukoze koje pokazuju druga\u010diji profil odgovora od dual agonista<\/li>\n<\/ul>\n<p>Ovi nalazi su razlog zbog kojeg Retatrutide privla\u010di sve ve\u0107i interes kao najnapredniji metaboli\u010dki istra\u017eiva\u010dki alat u ovoj klasi.<\/p>\n<h2>Retatrutide vs Tirzepatide za hrvatske istra\u017eiva\u010de<\/h2>\n<p>Ako vas eksperiment zahtijeva prou\u010davanje GLP-1\/GIP interakcije bez Glucagon varijable \u2014 Tirzepatide. Ako istra\u017eujete trostruki receptorski sinergizam, posebno hepati\u010dku komponentu \u2014 Retatrutide. Cellmind nudi oba u identi\u010dnom formatu \u010disto\u0107e, \u0161to eliminira kvalitetu materijala kao varijablu u komparativnim studijama.<\/p>\n<h2>Specifikacije i dostava u Hrvatsku<\/h2>\n<ul>\n<li>Dostupno: 10 mg i 30 mg<\/li>\n<li>\u010cisto\u0107a: &gt;99% HPLC<\/li>\n<li>CoA: prilo\u017een uz svaku narud\u017ebu<\/li>\n<li>Dostava HR: 48\u201372 sata, bez carinske procedure<\/li>\n<li>Sterilna voda za rekonstituciju: uklju\u010dena bez doplate<\/li>\n<\/ul>\n<p>Za narud\u017ebe: <a href=\"https:\/\/staging.bycellmind.com\/hr\/\">staging.bycellmind.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dok biohacking zajednica u Hrvatskoj tek po\u010dinje ozbiljnije razgovarati o GLP peptidima, istra\u017eiva\u010dka zajednica globalno ve\u0107 intenzivno prou\u010dava sljede\u0107i korak \u2014 triple receptor aktivaciju.<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","jetpack_post_was_ever_published":false},"categories":[258],"tags":[264],"class_list":["post-2017","post","type-post","status-publish","format-standard","hentry","category-blog","tag-retatrutide"],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/staging.bycellmind.com\/hr\/wp-json\/wp\/v2\/posts\/2017","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/staging.bycellmind.com\/hr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staging.bycellmind.com\/hr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staging.bycellmind.com\/hr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/staging.bycellmind.com\/hr\/wp-json\/wp\/v2\/comments?post=2017"}],"version-history":[{"count":0,"href":"https:\/\/staging.bycellmind.com\/hr\/wp-json\/wp\/v2\/posts\/2017\/revisions"}],"wp:attachment":[{"href":"https:\/\/staging.bycellmind.com\/hr\/wp-json\/wp\/v2\/media?parent=2017"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staging.bycellmind.com\/hr\/wp-json\/wp\/v2\/categories?post=2017"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staging.bycellmind.com\/hr\/wp-json\/wp\/v2\/tags?post=2017"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}